Pathologists at the Leading Edge of Optimizing the Tumor Tissue Journey for Diagnostic Accuracy and Molecular Testing

OBJECTIVES: Tumor biomarker analyses accompanying immuno-oncology therapies are coupled with a tumor tissue journey aiming to guide tissue procurement and allow for accurate diagnosis and delivery of test results. The engagement of pathologists in the tumor tissue journey is essential because they a...

Descripción completa

Detalles Bibliográficos
Autores principales: De Las Casas, Luis E, Hicks, David G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8130880/
https://www.ncbi.nlm.nih.gov/pubmed/33582767
http://dx.doi.org/10.1093/ajcp/aqaa212

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8130880/
https://www.ncbi.nlm.nih.gov/pubmed/33582767
http://dx.doi.org/10.1093/ajcp/aqaa212

Ejemplares similares